# Study To Assess The Pharmacokinetics Of 2 Different Formulations Of PF-04991532

> **NCT01388829** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 10 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Treatment A
- **DRUG:** Treatment B

## Key facts

- **NCT ID:** NCT01388829
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2011-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01388829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01388829, "Study To Assess The Pharmacokinetics Of 2 Different Formulations Of PF-04991532". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01388829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*